OWP
GMAB icon

ORG Wealth Partners’s Genmab GMAB Stock Holding History

ORG Wealth Partners’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.76K Sell
137
-163
-54% -$4.33K ﹤0.01% 603
2026
Q1 		$8.05K Buy
300
+151
+101% +$4.53K ﹤0.01% 525
2025
Q4 		$4.59K Buy
+149
New +$4.64K ﹤0.01% 524

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

ORG Wealth Partners's GMAB Position: Q2 2026 in Review

ORG Wealth Partners reduced its Genmab (GMAB) stake by 54% in Q2 2026, selling an estimated $4.33K and leaving 137 shares worth $3.76K. The position accounts for ﹤0.01% of the portfolio, ranked #603.

ORG Wealth Partners first reported a position in GMAB in Q4 2025 and has held it in 3 quarters since. The position peaked at $8.05K in Q1 2026. 289 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • ORG Wealth Partners held 137 shares of Genmab worth $3.76K as of Q2 2026.
  • ORG Wealth Partners sold 163 Genmab shares in Q2 2026, an estimated $4.33K.
  • Genmab made up ﹤0.01% of ORG Wealth Partners's portfolio in Q2 2026, its #603 holding.
  • ORG Wealth Partners first reported a position in Genmab in Q4 2025 and has held it in 3 quarters since.
  • ORG Wealth Partners's Genmab position peaked at $8.05K in Q1 2026.
  • 289 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on ORG Wealth Partners's 13F filing for Q2 2026, filed 27 Jul 2026.